← Leaderboards
Marie Demay
Massachusetts General Hospital
$19,218,520
Attributed
$21,370,770
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,962,051 · 17
By mechanism
R01$14,807,961 · 6
P30$7,539,814 · 3
P01$6,870,482 · 6
P50$2,150,674 · 1
R21$593,120 · 1
Top collaborators
- Henry M Kronenberg14 shared
- Andrew P Mcmahon9 shared
- Clifford J Tabin9 shared
- Benjamin Z Leder5 shared
- Mary L Bouxsein1 shared
- Paola Pajevic Divieti1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Benjamin Z Leder$7,400,681
- Sam Sunghyun Yoon$2,703,621
- Michael Mannstadt$4,555,232
- Hilary F Luderer$1,309,742
- Jason R. McCarthy$8,263,208
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseSkeletalCellsBoneInvestigationMolecularSignal TransductionIn VivoPhenotypeChondrocytesBiologyEpiphysial CartilageInorganic PhosphateHypophosphatemiaRicketsGrowthMediatingPathway InteractionsOsteoblastsResponseMouse ModelApoptosisHormonesIn Vitro
Grant awards (74)
Administrative Core$260,348
P30 · FY2025 · AR · contact PI
Center for Musculoskeletal Research$840,161
P30 · FY2024 · AR · contact PI
Administrative Core$330,642
P30 · FY2024 · AR · contact PI
Center for Skeletal Research (Overall Application)$841,664
P30 · FY2023 · AR
Center for Skeletal Research (Overall Application)$841,664
P30 · FY2022 · AR
Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration$509,054
R01 · FY2022 · AR
Center for Skeletal Research (Overall Application)$841,664
P30 · FY2021 · AR
Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration$567,473
R01 · FY2021 · AR
Hormonal and Molecular Etiology of Skeletal Abnormalities in XLH$356,485
R01 · FY2021 · AR · contact PI
Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration$68,659
R01 · FY2021 · AR
Center for Skeletal Research (Overall Application)$841,664
P30 · FY2020 · AR
Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration$574,528
R01 · FY2020 · AR
Hormonal and Molecular Etiology of Skeletal Abnormalities in XLH$367,511
R01 · FY2020 · AR · contact PI
Optimizing Calcitriol Monotherapy for X-Linked Hypophosphatemia: Effects on Mineral Ions, Growth and Skeletal Parameters$185,350
R21 · FY2020 · AR · contact PI
Center for Skeletal Research (Overall Application)$891,164
P30 · FY2019 · AR
Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration$519,014
R01 · FY2019 · AR
Hormonal and Molecular Etiology of Skeletal Abnormalities in XLH$367,511
R01 · FY2019 · AR · contact PI
Optimizing Calcitriol Monotherapy for X-Linked Hypophosphatemia: Effects on Mineral Ions, Growth and Skeletal Parameters$222,420
R21 · FY2019 · AR · contact PI
Hormonal and Molecular Etiology of Skeletal Abnormalities in XLH$367,511
R01 · FY2018 · AR · contact PI
Skeletal Phenotyping Core$290,677
P30 · FY2018 · AR · contact PI
Optimizing Calcitriol Monotherapy for X-Linked Hypophosphatemia: Effects on Mineral Ions, Growth and Skeletal Parameters$185,350
R21 · FY2018 · AR · contact PI
Skeletal Phenotyping Core$390,042
P30 · FY2017 · AR · contact PI
Hormonal and Molecular Etiology of Skeletal Abnormalities in XLH$367,511
R01 · FY2017 · AR · contact PI
Skeletal Phenotyping Core$390,040
P30 · FY2016 · AR · contact PI
Developmental Regulation of Bone Morphogenesis$1,392,444
P01 · FY2015 · DK
The Vitamin D Receptor:Ligand-Dependent and Independent Actions$445,397
R01 · FY2015 · DK · contact PI
Etiology and Therapy of Rickets in the Hyp mouse model of XLH$391,500
R01 · FY2015 · AR · contact PI
Skeletal Phenotyping Core$390,042
P30 · FY2015 · AR · contact PI
The Vitamin D Receptor: Ligand-Dependent and Independent Actions$44,661
R01 · FY2015 · DK · contact PI
Developmental Regulation of Bone Morphogenesis$1,388,239
P01 · FY2014 · DK
Skeletal Phenotyping Core$390,042
P30 · FY2014 · AR · contact PI
Etiology and Therapy of Rickets in the Hyp mouse model of XLH$383,670
R01 · FY2014 · AR · contact PI
The Vitamin D Receptor:Ligand-Dependent and Independent Actions$368,837
R01 · FY2014 · DK · contact PI
Developmental Regulation of Bone Morphogenesis$1,335,435
P01 · FY2013 · DK
Etiology and Therapy of Rickets in the Hyp mouse model of XLH$371,925
R01 · FY2013 · AR · contact PI
The Vitamin D Receptor:Ligand-Dependent and Independent Actions$355,929
R01 · FY2013 · DK · contact PI
Comparison of Bisphosphonate Treatment Regimens on Skeletal Growth & Biomechanics$290,563
R01 · FY2013 · AR · contact PI
Developmental Regulation of Bone Morphogenesis$1,377,182
P01 · FY2012 · DK
Etiology and Therapy of Rickets in the Hyp mouse model of XLH$391,688
R01 · FY2012 · AR · contact PI
The Vitamin D Receptor:Ligand-Dependent and Independent Actions$368,837
R01 · FY2012 · DK · contact PI
Comparison of Bisphosphonate Treatment Regimens on Skeletal Growth & Biomechanics$305,856
R01 · FY2012 · AR · contact PI
Project 1 Kronenberg$276,468
P01 · FY2012 · DK
Project 3 - Tabin$275,179
P01 · FY2012 · DK
Core A- Tabin$275,179
P01 · FY2012 · DK
Core B - Demay$275,179
P01 · FY2012 · DK
Proect 2 - McMahon$275,177
P01 · FY2012 · DK
Etiology and Therapy of Rickets in the Hyp mouse model of XLH$398,250
R01 · FY2011 · AR · contact PI
The Vitamin D Receptor:ligand-dependent and independent actions$368,837
R01 · FY2011 · DK · contact PI
Comparison of Bisphosphonate Treatment Regimens on Skeletal Growth & Biomechanics$305,856
R01 · FY2011 · AR · contact PI
P2: Phosphate, PTH, and FGF23 as mediators of the rachitic growth plate$324,316
P50 · FY2010 · AR · contact PI
Comparison of Bisphosphonate Treatment Regimens on Skeletal Growth & Biomechanics$318,600
R01 · FY2010 · AR · contact PI
VITAMIN D RECEPTOR ABLATION: DIRECT AND INDIRECT CONSEQUENCES$291,923
R01 · FY2010 · DK · contact PI
VITAMIN D RECEPTOR ABLATION: DIRECT AND INDIRECT CONSEQUENCES$27,656
R01 · FY2010 · DK · contact PI
P2: Phosphate, PTH, and FGF23 as mediators of the rachitic growth plate$532,866
P50 · FY2009 · AR · contact PI
VITAMIN D RECEPTOR ABLATION: DIRECT AND INDIRECT CONSEQUENCES$294,871
R01 · FY2009 · DK · contact PI
P2: Phosphate, PTH, and FGF23 as mediators of the rachitic growth plate$386,860
P50 · FY2008 · AR · contact PI
VITAMIN D RECEPTOR ABLATION: DIRECT AND INDIRECT CONSEQUENCES$294,871
R01 · FY2008 · DK · contact PI
P2: Phosphate, PTH, and FGF23 as mediators of the rachitic growth plate$568,403
P50 · FY2007 · AR · contact PI
REGULATION OF OSTEOBLAST GENE EXPRESSION$372,471
R01 · FY2007 · DK · contact PI
VITAMIN D RECEPTOR ABLATION: DIRECT AND INDIRECT CONSEQUENCES$300,889
R01 · FY2007 · DK · contact PI
REGULATION OF OSTEOBLAST GENE EXPRESSION$383,595
R01 · FY2006 · DK · contact PI
P2: Phosphate, PTH, and FGF23 as mediators of the rachitic growth plate$338,229
P50 · FY2006 · AR · contact PI
VITAMIN D RECEPTOR ABLATION: DIRECT AND INDIRECT CONSEQUENCES$317,582
R01 · FY2006 · DK · contact PI
REGULATION OF OSTEOBLAST GENE EXPRESSION$392,826
R01 · FY2005 · DK
GENETIC REGULATION OF CALCIUM METABOLISM$250,915
R01 · FY2005 · DK
REGULATION OF OSTEOBLAST GENE EXPRESSION$392,826
R01 · FY2004 · DK
GENETIC REGULATION OF CALCIUM METABOLISM$250,915
R01 · FY2004 · DK
REGULATION OF OSTEOBLAST GENE EXPRESSION$387,336
R01 · FY2003 · DK
GENETIC REGULATION OF CALCIUM METABOLISM$250,915
R01 · FY2003 · DK
GENETIC REGULATION OF CALCIUM METABOLISM$287,244
R01 · FY2002 · DK
REGULATION OF OSTEOBLAST GENE EXPRESSION$345,083
R01 · FY2001 · DK
GENETIC REGULATION OF CALCIUM METABOLISM$228,049
R01 · FY2001 · DK
REGULATION OF OSTEOBLAST GENE EXPRESSION$338,961
R01 · FY2000 · DK
GENETIC REGULATION OF CALCIUM METABOLISM$223,370
R01 · FY2000 · DK